CA1103154A - Compositions pharmaceutiques renfermant des derives organiques de la montmorillonite - Google Patents

Compositions pharmaceutiques renfermant des derives organiques de la montmorillonite

Info

Publication number
CA1103154A
CA1103154A CA281,533A CA281533A CA1103154A CA 1103154 A CA1103154 A CA 1103154A CA 281533 A CA281533 A CA 281533A CA 1103154 A CA1103154 A CA 1103154A
Authority
CA
Canada
Prior art keywords
dimethyl
montmorillonite
pharmaceutical compositions
animals
bentone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA281,533A
Other languages
English (en)
French (fr)
Inventor
Andre Queuille
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Application granted granted Critical
Publication of CA1103154A publication Critical patent/CA1103154A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA281,533A 1976-07-01 1977-06-28 Compositions pharmaceutiques renfermant des derives organiques de la montmorillonite Expired CA1103154A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR76-20143 1976-07-01
FR7620143A FR2356425A1 (fr) 1976-07-01 1976-07-01 Application a titre de medicaments de derives organiques de la montmorillonite

Publications (1)

Publication Number Publication Date
CA1103154A true CA1103154A (fr) 1981-06-16

Family

ID=9175127

Family Applications (1)

Application Number Title Priority Date Filing Date
CA281,533A Expired CA1103154A (fr) 1976-07-01 1977-06-28 Compositions pharmaceutiques renfermant des derives organiques de la montmorillonite

Country Status (10)

Country Link
US (1) US4096278A (OSRAM)
JP (1) JPS536410A (OSRAM)
AU (1) AU513829B2 (OSRAM)
BE (1) BE856319A (OSRAM)
CA (1) CA1103154A (OSRAM)
DE (1) DE2729824A1 (OSRAM)
FR (1) FR2356425A1 (OSRAM)
GB (1) GB1564458A (OSRAM)
NL (1) NL7707263A (OSRAM)
ZA (1) ZA773747B (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2001401A1 (en) * 1988-10-25 1990-04-25 Claude Piantadosi Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
US5244913A (en) * 1991-11-19 1993-09-14 Baxter International Inc. Compositions and methods for dissolving body calculi
ATE226437T1 (de) * 1993-06-10 2002-11-15 Univ Wake Forest (phospho)lipide zum bekämpfen einer hepatitis b- infektion
US7135584B2 (en) * 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
EP0781138B1 (en) * 1994-08-29 2008-05-21 Wake Forest University Lipid analogs for treating viral infections
US7026469B2 (en) * 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
US7309696B2 (en) 2000-10-19 2007-12-18 Wake Forest University Compositions and methods for targeting cancer cells
WO2002096826A2 (en) * 2001-05-29 2002-12-05 Koninklijke Philips Electronics N.V. Metal-ceramic bond
MXPA04001917A (es) * 2001-08-31 2004-06-15 Thomson Licensing Sa Contador de secuencia para una corriente audio-visual.
US20050187191A1 (en) * 2004-02-20 2005-08-25 Kucera Louis S. Methods and compositions for the treatment of respiratory syncytial virus
US20120058157A1 (en) * 2007-05-23 2012-03-08 Amcol International Corporation Methods of Treating Cardiovascular Disorders Associated with Atherosclerosis
US8481084B2 (en) * 2007-05-23 2013-07-09 Amcol International Corporation Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal
CA2716835A1 (en) * 2008-02-27 2009-09-03 Amcol International Corporation Methods of treating cardiovascular disorders associated with atherosclerosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016209A (en) * 1975-04-23 1977-04-05 Merck & Co., Inc. 3-[N'-(3-Halopropyl)-N-'-methylamino]-N,N,N-trimethyl-1-propanaminium halide and acid addition salts thereof

Also Published As

Publication number Publication date
FR2356425A1 (fr) 1978-01-27
US4096278A (en) 1978-06-20
GB1564458A (en) 1980-04-10
ZA773747B (en) 1978-07-26
DE2729824A1 (de) 1978-01-05
NL7707263A (nl) 1978-01-03
AU2661577A (en) 1979-01-04
JPS536410A (en) 1978-01-20
BE856319A (fr) 1977-12-30
FR2356425B1 (OSRAM) 1978-12-15
AU513829B2 (en) 1981-01-08

Similar Documents

Publication Publication Date Title
CA1103154A (fr) Compositions pharmaceutiques renfermant des derives organiques de la montmorillonite
EP0937085A1 (fr) Le (-)hydroxycitrate de magnesium, procede de preparation, applications, et compositions notamment pharmaceutiques le renfermant
BE895724A (fr) Nouvelle utilisation therapeutique de la dihydrocyclosporine d
EP0957928A1 (fr) Compositions d'extraits de plantes, leur procede de preparation, et compositions pharmaceutiques les renfermant
FR2655545A1 (fr) Nouvelle application therapeutique des derives des fluoroquinolones.
DE60032915T2 (de) Gallium komplexe von 3-hydroxy-4-pyronen zur behandlung von durch intrazelluläre prokaryoten, dns- und retro-viren verursachten infektionen
DE60132374T2 (de) Alpha-ketoglutarate von wirkstoffen und deren zusammensetzungen
EP1154766A2 (de) Verwendung von r-arylpropionsäuren zur herstellung von arzneimitteln, zur behandlung von erkrankungen bei mensch und tier, welche durch die hemmung der aktivierung von nf-kappa b therapeutisch beeinflusst werden können
JPS60120995A (ja) 新規アミノ酸誘導体の製法
FR2596650A1 (fr) Compositions pharmaceutiques a activite metabolique comportant un coenzyme ubiquinonique et un extrait de panax
EP0739629B1 (fr) Nouvelles associations comprenant du (-)hydroxycitrate et présentant notamment de nouvelles activités thérapeutiques
CA1059913A (fr) Compositions pharmaceutiques
CA1187785A (fr) Medicament a base de l-methionine
FR2467596A1 (fr) Compositions pharmaceutiques de tiaramide ou de son sel et d'un agent reglant la dissolution, a longue duree d'action
CH651032A5 (fr) Phenoxyisobutyrates de moroxydine et medicaments les contenant.
EP0631777B1 (fr) Utilisation de dérivés de la bêta-naphtoquinone pour l'inhibition de l'agrégation plaquettaire
FR2547730A1 (fr) Medicament hypolipidemiant contenant comme ingredient actif la d-3-acetoxy-cis-2,3-dihydro-5-(2-(dimethylamino)ethyl)-2-(p-methoxyphenyl)-1,5-benzothiazepine-4(5h)-one ou un de ses sels d'addition d'acides acceptables en pharmacie
EP1523321B1 (fr) Utilisation d'extraits de ginkgo biloba pour favoriser la masse musculaire au detriment de la masse graisseuse
FR2605222A1 (fr) Agent therapeutique a base de nitrate de n-(2-hydroxyethyl) nicotinamide pour le traitement de troubles associes a l'ischemie cerebrale
FR2605221A1 (fr) Compositions pharmaceutiques ou veterinaires contenant de la de(hydroxymethyl)-25 deoxy-25 oxo-25 monensine
EP0308349B1 (fr) Nouveau derivé de choline, son procédé de préparation et nouveaux médicaments le contenant
FR2518880A1 (fr) Compositions therapeutiques a activite choleretique, contenant a titre de principe actif, des derives de l'acide cholanique
FR2711527A1 (fr) Utilisation de l'acriflavine comme agent anti HIV.
FR2585573A1 (fr) Medicament pour prevenir l'abus d'alcool
LU87777A1 (fr) Nouvelle forme galenique orale ameliorant la biodisponibilite

Legal Events

Date Code Title Description
MKEX Expiry